AGFB 📈 AGFA Gevaert - Overview

Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0003755692

AGFB: Imaging Systems, Printers, Inkjet Inks, X-ray Film, Healthcare Software

Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems worldwide. It operates through four segments: HealthCare IT, Digital Print & Chemicals, Radiology Solutions, and CONOPS. The company's CONOPS segment engages in supply of film and chemicals, as well support services. Its Radiology Solutions segment offers analog and digital imaging technology for diagnostic imaging market to meet the needs of specialized clinicians in hospitals and imaging centers; and X-ray film, hardcopy film and printers, digital radiography equipment, and image processing software. The company's Healthcare IT segment provides healthcare's enterprise imaging platform. Its Digital Print & Chemicals segment offers inkjet printers for sign and display and packaging printing companies; inkjet inks and fluids for industrial inkjet applications, such as signs, posters and displays, promotional materials, packaging, leather goods, laminated flooring, and decorative materials, as well as for printed electronics industry; electrolysis membranes to the hydrogen production industry, as well as for printable synthetic papers. This segment also provides films for micrography, non-destructive testing, aerial photography and printed circuit board production; membranes for green hydrogen production; and conductive polymers and materials for the production of high-security ID documents. The company sells its products through its own sales organization, as well as through a network of agents and representatives. Agfa-Gevaert NV was founded in 1867 and is headquartered in Mortsel, Belgium. Web URL: https://www.agfa.com

Additional Sources for AGFB Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

AGFB Stock Overview

Market Cap in USD 125m
Sector Industrials
Industry Specialty Industrial Machinery
GiC Sub-Industry Health Care Technology
IPO / Inception

AGFB Stock Ratings

Growth 5y -92.5%
Fundamental -47.6%
Dividend 7.09%
Rel. Strength Industry -2228
Analysts -
Fair Price Momentum 0.41 EUR
Fair Price DCF -

AGFB Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y 0.00%
Payout Consistency 23.6%

AGFB Growth Ratios

Growth Correlation 3m -89.5%
Growth Correlation 12m -78.4%
Growth Correlation 5y -85.6%
CAGR 5y -31.08%
CAGR/Mean DD 5y -0.80
Sharpe Ratio 12m -1.31
Alpha -68.57
Beta 0.60
Volatility 43.80%
Current Volume 230.9k
Average Volume 20d 252.8k
What is the price of AGFB stocks?
As of December 22, 2024, the stock is trading at EUR 0.70 with a total of 230,895 shares traded.
Over the past week, the price has changed by -11.84%, over one month by +9.90%, over three months by -39.80% and over the past year by -49.62%.
Is AGFA Gevaert a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, AGFA Gevaert (BR:AGFB) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -47.64 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AGFB as of December 2024 is 0.41. This means that AGFB is currently overvalued and has a potential downside of -41.43%.
Is AGFB a buy, sell or hold?
AGFA Gevaert has no consensus analysts rating.
What are the forecast for AGFB stock price target?
According to ValueRays Forecast Model, AGFB AGFA Gevaert will be worth about 0.5 in December 2025. The stock is currently trading at 0.70. This means that the stock has a potential downside of -34.29%.
Issuer Forecast Upside
Wallstreet Target Price 1.3 90%
Analysts Target Price - -
ValueRay Target Price 0.5 -34.3%